Amy Butte - Bain Capital Independent Director
| BCSF Stock | USD 18.17 0.31 1.74% |
Insider
Amy Butte is Independent Director of Bain Capital Specialty since 2019.
| Age | 52 |
| Tenure | 6 years |
| Phone | 617 516 2000 |
| Web | https://www.baincapitalspecialtyfinance.com |
Amy Butte Latest Insider Activity
Tracking and analyzing the buying and selling activities of Amy Butte against Bain Capital stock is an integral part of due diligence when investing in Bain Capital. Amy Butte insider activity provides valuable insight into whether Bain Capital is net buyers or sellers over its current business cycle. Note, Bain Capital insiders must abide by specific rules, including filing SEC forms every time they buy or sell Bain Capital'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Amy Butte over six months ago Disposition of 5220 shares by Amy Butte of DigitalOcean Holdings at 37.46 subject to Rule 16b-3 | ||
Amy Butte over six months ago Disposition of 3760 shares by Amy Butte of DigitalOcean Holdings at 36.8 subject to Rule 16b-3 |
Bain Capital Management Efficiency
The company has return on total asset (ROA) of 0.0522 % which means that it generated a profit of $0.0522 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1126 %, meaning that it created $0.1126 on every $100 dollars invested by stockholders. Bain Capital's management efficiency ratios could be used to measure how well Bain Capital manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Ciara Crawford | DWS Municipal Income | 36 | |
| Marco Collazos | WhiteHorse Finance | 49 | |
| R Hubbard | Blackrock Innovation Growth | 63 | |
| Mark Jenkins | Carlyle Secured Lending | 58 | |
| Jonathan Diorio | Blackrock Innovation Growth | 41 | |
| Alan Oshiki | Triplepoint Venture Growth | N/A | |
| Debra Rubano | Allianzgi Diversified Income | 45 | |
| Cynthia Fornelli | Triplepoint Venture Growth | 59 | |
| Katherine Park | Triplepoint Venture Growth | N/A | |
| Grishma Parekh | Carlyle Secured Lending | N/A | |
| CPA CPA | BlackRock ESG Capital | 60 | |
| Taylor Boswell | Carlyle Secured Lending | 45 | |
| John II | Fidus Investment Corp | N/A | |
| Jeffrey Lee | BlackRock Health Sciences | N/A | |
| Matthew Shehorn | Fidus Investment Corp | N/A | |
| Robert Fairbairn | Blackrock Resources Commodities | 56 | |
| Joshua JD | Golub Capital BDC | 50 | |
| J Holloman | Blackrock Muniyield | 66 | |
| Philip Mcloughlin | Allianzgi Diversified Income | 74 | |
| W Kester | Blackrock Muni Intermediate | 70 | |
| Catherine Schrand | DWS Municipal Income | N/A | |
Management Performance
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0522 |
Bain Capital Specialty Leadership Team
Elected by the shareholders, the Bain Capital's board of directors comprises two types of representatives: Bain Capital inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bain. The board's role is to monitor Bain Capital's management team and ensure that shareholders' interests are well served. Bain Capital's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bain Capital's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Hough, Independent Director | ||
| Sally Dornaus, Chief Financial Officer | ||
| Michael Boyle, Vice President Treasurer | ||
| Jay Margolis, Independent Director | ||
| James Goldman, Chief Compliance Officer | ||
| David Fubini, Independent Director | ||
| Jessica Yeager, Secretary | ||
| Jeffrey Hawkins, Chairman of the Board | ||
| Michael Treisman, Vice President Secretary | ||
| Derek Kirby, Investor Contact | ||
| Clare Richer, Independent Director | ||
| Amy Butte, Independent Director | ||
| Katherine Schneider, Investor Officer | ||
| Michael Ewald, Chief Executive Officer, Director | ||
| Amit Joshi, Chief Officer |
Bain Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bain Capital a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0522 | ||||
| Profit Margin | 0.44 % | ||||
| Operating Margin | 0.73 % | ||||
| Current Valuation | 2.43 B | ||||
| Shares Outstanding | 64.56 M | ||||
| Shares Owned By Insiders | 0.58 % | ||||
| Shares Owned By Institutions | 51.13 % | ||||
| Number Of Shares Shorted | 382.42 K | ||||
| Price To Earning | 10.38 X |
Currently Active Assets on Macroaxis
When determining whether Bain Capital Specialty is a strong investment it is important to analyze Bain Capital's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bain Capital's future performance. For an informed investment choice regarding Bain Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bain Capital Specialty. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Asset Management & Custody Banks space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bain Capital. If investors know Bain will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bain Capital listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bain Capital Specialty is measured differently than its book value, which is the value of Bain that is recorded on the company's balance sheet. Investors also form their own opinion of Bain Capital's value that differs from its market value or its book value, called intrinsic value, which is Bain Capital's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bain Capital's market value can be influenced by many factors that don't directly affect Bain Capital's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bain Capital's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bain Capital is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bain Capital's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.